Navigation Links
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis

-2 and the cascade of pro-inflammatory events contributing to organ transplant rejection and autoimmune and related diseases. Daclizumab is in development for MS by PDL and Biogen Idec, and separately by PDL in asthma and transplant maintenance. Hoffman-La Roche, Inc. currently markets daclizumab under the name Zenapax(R) under a license from PDL. Zenapax antibody is indicated for the prophylaxis of acute organ rejection in patients receiving renal transplants.

About Biogen Idec

Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com .

About PDL BioPharma

PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Commercially focused in the acute-care hospital setting, PDL markets and sells its portfolio of leading products in the United States and Canada. A pioneer of antibody humanization technology, PDL promotes this technology through licensing agreements and clinical development of its own diverse pipeline of investigational compounds. PDL's research platform centers on the discovery and development of antibodies to treat cancer and autoimmune diseases. For more information, please visit www.pdl.com .

Forward-looking Statement

The information in this press release should be considered accurate only as of the date of the release. Neither PDL nor Biogen Idec has any intention of updating and specifically disclaims any duty to update the information in this press release for any reason, except as r
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. ENDEAVOR IV Clinical Trial Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
5. Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint
6. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
7. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
8. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
9. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
10. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
11. Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints

Post Your Comments:
(Date:11/25/2009)... According to Millennium Research G...logy market intelligence, the nearly $3 billion US...to see rapid growth over the next five years despi... for Trauma Devices 2010 report finds that this...ive years, with competitors introducing specialize...
(Date:11/25/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, Pain Management - Global Trends ,, ...ent---Global-Trends.html ,, Widespread availab...nt clinics, and the advent of new drugs have accel...arket. Healthcare reforms and reimbursement struct...
(Date:11/25/2009)..., Nov. 25 HeartWare Inte...ing innovator and provider of less invasive, minia...nizing the treatment of advanced heart failure, to...stor presentation at the 21st Annual Piper Jaffray...y, December 2, 2009. The conference is being held ...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Neogen to Ring NASDAQs Closing Bell 14815 1Neogen to Ring NASDAQs Closing Bell 14815 2Health Robotics Reaches 100 25 Asia Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea 6218 1Health Robotics Reaches 100 25 Asia Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea 6218 2Health Robotics Reaches 100 25 Asia Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea 6218 3New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm Eggs and Other Materials for Each Patient 6215 1New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm Eggs and Other Materials for Each Patient 6215 2New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm Eggs and Other Materials for Each Patient 6215 3
... Gathered to Assist in Design of Future Trials, Ot...tugal, April 26, 2007,/PRNewswire-FirstCall/ -- Io...-patient, Phase 2 dose-ranging trial of its patch-...as conducted to assess,the ability of a range of v...t enterotoxigenic E. coli (ETEC) bacteria -- the,m...
...OURG, France and VANCOUVER, April 26, 2007,/PRNews..., a global,specialty pharmaceutical and medical de...m its European pivotal trial examining the,Vascula...(TM)"),will be presented today at a scientific for...ty and efficacy of the Vascular,Wrap(TM) for use i...
Other Medicine Technology:Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for,Travelers' Diarrhea Stimulates Immune Response Even at Low Doses 2Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for,Travelers' Diarrhea Stimulates Immune Response Even at Low Doses 3Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for,Travelers' Diarrhea Stimulates Immune Response Even at Low Doses 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7
(Date:11/29/2009)... Traditional healthcare,s uncertain future ...le alternative care. Affordable Acupuncture Scotts...(PRWEB) November 29, 2009 -- Affordable Acupunctur...2009) and has been met with enthusiasm and gratitu...n be attributed to two things, need and cost. &qu...
(Date:11/28/2009)...ere more likely to consider change after 30-minute... , FRIDAY, Nov. 27 (HealthDay News) -- A program ... they should stop their dangerous behavior may lea...hers have found. , The new study included 184 m...ed convictions, who were randomly assigned to one ...
(Date:11/27/2009)...RD, Mass., Nov. 27 GSI G...upplier of precision technology products and semic...eeting of the Company,s shareholders has been sche...cation of the meeting will be announced in due cou...d a requisition notice from Stephen Bershad, a hol...
(Date:11/27/2009)..., Nov. 27 Considered a ...nly 25 years ago, solid organ transplantation is n...e extraordinary men and women who gathered at the ... came together from medical centers around the wor...ional Transplant Institute (BRTI), one of the pion...
(Date:11/27/2009)...LLY-SUR-SEINE, France, Nov. 27 Tea...al cycling team dedicated to ethical sporting and ...s, announced today that it will become Team Garmin...cal as a new sponsor of the team. Transitions Opti...e eyewear, offering the most advanced photochromic...
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3
... healthcare provider will soon be reaching out to ...to provide treatment and support//. The US-ba...hree voluntary counselling and testing centres in ...) and AHF recently signed a memorandum of understa...
...rug users (IDUs) in India, heroin is no more a fav...f pharmaceutical preparations//, especially painki...gh, experts said here Monday. Many such addi... initiative on HIV and AIDS, and other organisatio...
...es, the biotechnology venture of Mukesh Ambani's R...eins or blood products and building// a world clas...been encouraged to set up a manufacturing unit due...rious blood clotting disorders. "Encouraged...
...e assembly Monday unanimously passed a resolution ... that makes it mandatory// for 50 percent of the '...ry warning signal. On the first day of the w...kers. The resolution moved by Chief Ministe...
...ity, Hissar Monday tied up with the College of Agr...f Maryland to conduct joint research// for develop... research between both universities will also be f...tricia Hayers-Parker, said that the patent of the ...
... Americans, especially the senior citizens have be... have managed// to bring their blood pressure unde..., said,"It is hard to attribute the improvement to...t increase in these, so probably all of these cont...
Other Medicine News:Health News:US NGO to Counsel HIV/AIDS Patients in Assam 2Health News:Addicts in India Taking to Pharmaceutical Drugs: UNAIDS 2Health News:Andhra Wants Withdrawal of Warning Signal from ‘Beedi’ Packe 2
Replacement Bulb: DZE/FDS
Replacement Bulb: DDL
...hony family of Pacemakers, Ela presents the most a...r than a passport, will take your patients further... and delivering powerful monitoring. ELA dual cham... and atrial tracking modes in patients who may ben...
... Measuring System delivers precise and accurate Me...y are receiving a better examination when they see... ,User Friendly - after only 5 minutes of proper...y proficient in the operation of this instrument a...
Medicine Products: